Recent News | US Food and Drug Administration

LA Wildfires Worsen Respiratory Issues for Locals

The Los Angeles wildfires have sparked widespread loss and grief, affecting mental health in the region. According to experts, the physical effects of wildfire smoke are also a concern, as it can exacerbate respiratory issues such as asthma and chronic obstructive pulmonary disease (COPD). The US Food and Drug Administration (FDA) has banned red food dye due to its potential cancer risk, calling it a "long time coming" decision.

https://www.foxnews.com/health/wildfire-health-impacts-plus-fda-bans-red-food-dye

BlinkLab Dx Nears FDA Approval Milestone

BlinkLab Limited, a company listed on the Australian Securities Exchange as AU:BB1, has made significant progress in its pursuit of FDA clearance for its autism diagnostic app, BlinkLab Dx. The company recently had a positive outcome from a Pre-Submission meeting with the US Food and Drug Administration (FDA), confirming the study design and data requirements needed for approval. A large-scale clinical trial involving up to 1,000 children across multiple sites in the US is currently underway, aiming to be completed within 12-16 months.

https://markets.businessinsider.com/news/stocks/blinklab-advances-toward-fda-approval-for-autism-app-1034153865